Novel peptidomimetic cyclo-{E(I)-E(W)}Na (CP-88) with hematopoietic activity sustained in invasive and oral administration: experimental and preclinical evaluation

Abstract

The aim of this work is to study novel peptidomimetics with hematopoietic activity sustained in invasive and oral administration. The results of this investigation underscore the significant potential of CP-88 peptide as a hematopoiesis-regulated drug and instill optimism for its future application in medical practice